CASC may be involved in anti-tumor immune response through the modulation of NAD plus dependent energy metabolism

被引：0
|
作者：
Misawa, Aya [1 ]
Ohta, Shigeki [1 ]
Ikeda, Atsushi [2 ]
Takimoto, Tetsuya [2 ]
Chaw, Kyithathu [1 ]
Kawakami, Yutaka [1 ]
机构：
[1] IUHW Med Immunol, Chiba, Japan
[2] JSR, JKiC, Tokyo, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-2188
引用
收藏
页码：1402 / 1402
页数：1
相关论文
共 50 条
  • [31] An aqueous extract of Limoniastrum guyonianum gall induces anti-tumor effects in melanoma-injected mice via modulation of the immune response
    Krifa, M.
    Skandrani, I.
    Pizzi, A.
    Nasr, N.
    Ghedira, K.
    Chekir, L.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S26 - S26
  • [32] Synergistic Anti-Tumor Effects of the Novel HDAC Inhibitor, ABT-301, with Immune Checkpoint Inhibitors in Colorectal Cancer Through Regulation of Immune Response and Anti-Angiogenesis
    Tan, K. T.
    Lin, M. C.
    Hsu, T. A.
    Chang, C. F.
    Chang, S. M.
    Lin, C. T.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S117 - S117
  • [33] MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host
    Saito, T
    Kimura, M
    Kawasaki, T
    Sato, S
    Tomita, Y
    CANCER LETTERS, 1996, 109 (1-2) : 15 - 21
  • [34] Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway
    Zou, Tao
    Gu, Li
    Yang, Liqiong
    Wei, Junsong
    Zhao, Yueshui
    Shen, Jing
    Li, Mingxing
    Wu, Xu
    Du, Fukuan
    Chen, Yu
    Ye, Yun
    Xiao, Zhangang
    Wu, Zhigui
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2022, 17 (04) : 396 - 409
  • [35] Caffeine-enhanced anti-tumor immune response through decreased expression of PD1 on infiltrated cytotoxic T lymphocytes
    Tej, Gullanki Naga Venkata Charan
    Neogi, Kaushik
    Verma, Sumit Singh
    Gupta, Subash Chandra
    Nayak, Prasanta Kumar
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 859
  • [36] Targeting cathepsin B in the pancreatic stellate cells stimulates CD8+T cell dependent anti-tumor immune response.
    Garg, Bharti
    Jain, Tejeshwar
    Vaish, Utpreksha
    Dudeja, Vikas
    CANCER RESEARCH, 2021, 81 (22) : 74 - 75
  • [37] The RXR agonist, IRX4204, delays the formation of Brca1 mutant mammary tumors via modulation of the anti-tumor immune response
    Moyer, Cassandra
    Coleman, Darian
    Hill, Jamal
    Vornik, Lana A.
    Savage, Michelle
    Sanders, Martin
    Shizuko, Sei
    Mohammed, Altaf
    Brown, Powel
    Mazumdar, Abhijit
    CANCER RESEARCH, 2024, 84 (09)
  • [38] Radiation Therapy Induces an Adaptive Upregulation of PD-L1 on Tumor Cells Which May Limit the Efficacy of the Anti-Tumor Immune Response But Can Be Circumvented by Anti-PD-L1
    Illidge, T.
    Lipowska-Bhalla, G.
    Cheadle, E.
    Honeychurch, J.
    Poon, E.
    Morrow, M.
    Stewart, R.
    Wilkinson, R.
    Dovedi, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S776 - S776
  • [39] Tumor-associated extracellular vesicles from HPV plus oropharyngeal cancer lymphatic fluid trigger an anti-tumor response through activation of the cGAS-STING pathway
    Xu, Zhongping
    Earland, Noah
    Harris, Peter K.
    Gerndt, Sophie P.
    Ramirez, Ricardo
    Semenkovich, Nicholas P.
    Chaudhuri, Aadel A.
    Zevallos, Jose P.
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [40] APL-1202 enhances anti-tumor immune response through induction of cellular stress signaling and immunogenic cell death pathway in cancer cells
    Bam, Rakesh
    Guan, Jingmin
    Vellichirammal, Neetha Nanoth
    Manohar, Murli
    Mulholland, David
    Sfakianos, John
    Sun, Qiaoling
    Yi, Zuoan
    Chen, Alice
    CANCER RESEARCH, 2024, 84 (06)
12345